SCHEMBL19559710

SCHEMBL19559710

NN1C(=O)SC(Cc2ccc(OCCc3ccccc3)cc2)C1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ FFAR1 O14842 4/20 0.46
▸ CA12 O43570 1/20 0.45
▸ CA1 P00915 1/20 0.45
▸ CA2 P00918 1/20 0.45
▸ CA7 P43166 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ PPARG P37231 3/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ LTA4H P09960 1/20 0.42
▸ HPGD P15428 1/20 0.41
▸ PTPN1 P18031 2/20 0.40
▸ AKR1B1 P15121 1/20 0.40
▸ MAOB P27338 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ KDM4C Q9H3R0 1/20 0.40
▸ MAOA P21397 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19559801 0.90 PPARG (0.46) PPARGMAPTMAOBKDM4CMAOA
SCHEMBL19559762 0.89 PPARG (0.45) FFAR1PPARGKDM4C
SCHEMBL19559724 0.87 GLA (0.42) FFAR1PPARGLTA4HMAOB
SCHEMBL19559666 0.86 PPARG (0.46) FFAR1PPARGMAPTLTA4HMAOB
SCHEMBL19559652 0.85 PPARG (0.40) FFAR1PPARGKDM4EMAPTMAOB
SCHEMBL19559802 0.83 PPARG (0.41) FFAR1PPARGKDM4EMAPTHPGD
SCHEMBL19559657 0.80 PPARG (0.64) NPC1RAB9APPARGKDM4EMAPT
SCHEMBL19559726 0.79 PPARG (0.49) FFAR1PPARGKDM4EMAPTLTA4H
SCHEMBL18323953 0.79 PPARG (0.66) PPARGHPGDMEN1KMT2AKDM4C
SCHEMBL19559692 0.78 FFAR1 (0.41) FFAR1PPARGKDM4EMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2513070-B1 PPAR-SPARING THIAZOLIDINEDIONE SALTS FOR THE TREATMENT OF METABOLIC DISEASES CIRIUS THERAPEUTICS INC (US) 2017-11-08 — — EP disclosed
Send feedback